Back to top
more

Colfax Corporation (CFX)

(Delayed Data from NYSE)

$33.43 USD

33.43
1,327,278

+0.07 (0.21%)

Updated Nov 19, 2019 03:56 PM ET

After-Market: $33.46 +0.02 (0.06%) 5:39 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.62%
17.69%
9.40%
5.11%
2.01%
10.65%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value | C Growth | B Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Colfax (CFX) Q3 Earnings Beat Estimates, Up Y/Y on Buyouts

Colfax's (CFX) third-quarter 2019 results benefit from improved sales performance, with buyouts playing a significant role.

DOV GHM CFX BRC

Zacks Equity Research

Colfax (CFX) Surpasses Q3 Earnings Estimates

Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CFX

Zacks Equity Research

Analysts Estimate Colfax (CFX) to Report a Decline in Earnings: What to Look Out for

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CFX

Zacks Equity Research

Here's Why it is Worth Holding on to Colfax (CFX) Stock Now

Colfax (CFX) is likely to gain from opportunities in fabrication technology and orthopedic solutions businesses, buyouts, and emerging market exposure. High costs, huge debts and forex woes are dragging.

AZZ ESE CFX GHM

Zacks Equity Research

IDEX's Diversified Business and Buyouts Aid Despite Forex Woes

IDEX (IEX) gains from a diversified business structure, solid product offerings, acquired assets and shareholder-friendly policies. Geopolitical uncertainties and forex woes are headwinds.

XYL DOV IEX CFX

Zacks Equity Research

Colfax Completes Divestment of Air & Gas Handling Business

Colfax's (CFX) Air & Gas Handling divestment will help it pay down debts as well as concentrate on core and profitable businesses.

CFX GTLS MHVYF CRAWA

Zacks Equity Research

Reasons Why Investors Should Avoid Applied Industrial Now

Applied Industrial (AIT) suffers from forex-related woes, high debts, rising costs and uncertainties in the broader industrial cycle.

AIT CFX NDSN ROLL

Zacks Equity Research

Cintas (CTAS) to Post Q1 Earnings: What's in the Offing?

Cintas' (CTAS) first-quarter fiscal 2020 earnings to gain from solid product portfolio, enterprise resource planning system and acquired assets. Lower working days and high taxes are concerning.

CTAS CFX JBT BRC

Zacks Equity Research

Apogee (APOG) to Report Q2 Earnings: What's in the Cards?

Solid bidding and order activities, robust backlog and favorable North America commercial construction market likely to aid Apogee's (APOG) fiscal Q2 performance.

SON APOG CFX CENX

Zacks Equity Research

Is Colfax Corporation (CFX) a Great Pick for Value Investors?

Is Colfax Corporation (CFX) a great pick from the value investor's perspective right now? Read on to know more.

CFX

Zacks Equity Research

Colfax (CFX) Up 0.4% Since Last Earnings Report: Can It Continue?

Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CFX

Zacks Equity Research

Atkore (ATKR) Rallies 46% YTD: What's Driving the Stock?

Atkore (ATKR) benefits from volume growth in electrical categories, product launches and acquired assets. Its stock surges year to date, outperforming industry, sector and S&P 500.

WIRE BDC ATKR CFX

Zacks Equity Research

Colfax to Gain from Strong End Markets & Buyouts Amid Risks

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. However, rising cost of sales is a concern.

ROP CFX DXPE GHM

Zacks Equity Research

Colfax (CFX) Q2 Earnings Top Estimates, Sales Gain on Buyouts

Colfax's (CFX) second-quarter 2019 results benefit from improvement in core sales and acquired assets. It provides projections, after adjusting for the pending divestment of the Air and Gas Handling segment.

ROP CFX GHM DOV

Zacks Equity Research

Colfax (CFX) Beats Q2 Earnings Estimates

Colfax (CFX) delivered earnings and revenue surprises of 6.67% and -27.15%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CFX

Zacks Equity Research

Here's Why You Should Avoid Betting on Colfax (CFX) Stock Now

Colfax (CFX) might suffer from high costs and operating expenses, huge debt levels, and unfavorable movements in foreign currencies.

ROP GTLS CFX ROLL

Zacks Equity Research

Why Is Colfax (CFX) Down 0.2% Since Last Earnings Report?

Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CFX

Zacks Equity Research

Colfax (CFX) to Divest Air and Gas Handling Business to KPS

The divestiture of Air and Gas Handling business will enable Colfax (CFX) to reach its leverage target and raise profitability ratio.

ROP DOV DXPE CFX

Zacks Equity Research

Colfax (CFX) Poised to Gain From Buyouts, Suffers From Debts

Colfax's (CFX) acquisition of DJO Global marks its entry into the orthopedic solutions industry. High debts and forex woes remain concerning.

ROP CFX DOV DXPE

Zacks Equity Research

Colfax (CFX) Q1 Earnings Top Estimates, Gain From Buyouts

Colfax's (CFX) first-quarter 2019 results benefit from gains from acquired assets, especially DJO Global as well as improvement in existing businesses and margins.

ROP DOV CFX DXPE

Zacks Equity Research

Colfax (CFX) Q1 Earnings Surpass Estimates

Colfax (CFX) delivered earnings and revenue surprises of 8.16% and -2.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CFX

Zacks Equity Research

Emerson (EMR) to Report Q2 Earnings: Will it Disappoint?

Emerson's (EMR) second-quarter fiscal 2019 results are likely to be hurt by rising operating costs and expenses, and unfavorable movement in foreign currencies.

EMR CFX DXPE AAXN

Zacks Equity Research

Colfax (CFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Colfax (CFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CFX

Zacks Equity Research

5 Machinery Stocks Set to Surpass Q1 Earnings Estimates

Revenues for the machinery stocks are likely to decline sequentially in Q1. Read to know five machinery stocks that are poised to beat estimates in first-quarter 2019.

SWK CFX ITW DXPE ACCO TPIC AAXN

Zacks Equity Research

What's in Store for Advanced Emissions (ADES) in Q1 Earnings?

Advanced Emissions' (ADES) first-quarter 2019 earnings might gain from solid growth opportunities in the refined coal business and synergistic benefits from acquired assets. High costs are concerning.

CFX DXPE ADES AAXN